Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000242 ( Pmc/Corpus ); précédent : 0002419; suivant : 0002430 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Liquorice may tackle SARS</title>
<author>
<name sortKey="Pilcher, Helenr" sort="Pilcher, Helenr" uniqKey="Pilcher H" first="Helenr." last="Pilcher">Helenr. Pilcher</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmc">7095480</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095480</idno>
<idno type="RBID">PMC:7095480</idno>
<idno type="doi">10.1038/news030609-16</idno>
<idno type="pmid">NONE</idno>
<date when="2003">2003</date>
<idno type="wicri:Area/Pmc/Corpus">000242</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000242</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Liquorice may tackle SARS</title>
<author>
<name sortKey="Pilcher, Helenr" sort="Pilcher, Helenr" uniqKey="Pilcher H" first="Helenr." last="Pilcher">Helenr. Pilcher</name>
</author>
</analytic>
<series>
<title level="j">Nature</title>
<idno type="ISSN">0028-0836</idno>
<idno type="eISSN">1476-4687</idno>
<imprint>
<date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="Par1">After trying all sorts of compounds researchers say root extract looks promising.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Cinatl, J" uniqKey="Cinatl J">J Cinatl</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="news">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nature</journal-id>
<journal-id journal-id-type="iso-abbrev">Nature</journal-id>
<journal-title-group>
<journal-title>Nature</journal-title>
</journal-title-group>
<issn pub-type="ppub">0028-0836</issn>
<issn pub-type="epub">1476-4687</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmc">7095480</article-id>
<article-id pub-id-type="publisher-id">BFnews03060916</article-id>
<article-id pub-id-type="doi">10.1038/news030609-16</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Liquorice may tackle SARS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pilcher</surname>
<given-names>HelenR.</given-names>
</name>
</contrib>
</contrib-group>
<pub-date pub-type="epub">
<day>13</day>
<month>6</month>
<year>2003</year>
</pub-date>
<permissions>
<copyright-statement>© Nature Publishing Group 2003</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1" abstract-type="Standfirst">
<p id="Par1">After trying all sorts of compounds researchers say root extract looks promising.</p>
</abstract>
</article-meta>
</front>
<body>
<p id="Par2">
<fig position="anchor" id="Figa">
<caption>
<p>Liquorice's distinctive flavour is from glycyrrhizin.</p>
<p>© GettyImages</p>
</caption>
<graphic position="anchor" xlink:href="41586_2003_Article_BFnews03060916_Figa_HTML" id="d29e103"></graphic>
</fig>
</p>
<p id="Par3">Liquorice may prove an unlikely ally in the fight against sudden acute respiratory syndrome (SARS). In the lab at least, an extract of the plant's root blocks the SARS virus from growing inside cells, new research reveals
<sup>
<xref ref-type="bibr" rid="CR1">1</xref>
</sup>
.</p>
<p id="Par4">The study is part of an ongoing search for a treatment for SARS. The flu-like disease has claimed more than 750 lives since it emerged last year in Guangdong Province, China.</p>
<p id="Par5">High doses of the liquorice extract, called glycyrrhizin, practically wipe out the SARS virus in infected monkey cells, find virologist Jindrich Cinatl of Frankfurt University Medical School, Germany and his colleagues. The drug is more potent than ribavirin, the most commonly used treatment for SARS.</p>
<p id="Par6">Glycyrrhizin makes it difficult for the SARS virus to attach to and invade a target cell, the team found. It also hinders virus reproduction, slowing its spread from one cell to the next. </p>
<p id="Par7">"We don't have many leads [for effective drugs] at this point, so this is very exciting," says virologist Robert Baker from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland. Good nursing and hospital care are the best treatments at present, he explains.</p>
<p id="Par8">But glycyrrhizin has drawbacks: large amounts are needed to affect SARS-infected cells. "It's unlikely to result in a treatment for the disease," says biochemist Rolf Hilgenfeld who studies the virus at Lübeck University, Germany. "I can't imagine swallowing a tablet that big," he says.</p>
<p id="Par9">Nonetheless, the compound may lead to the development of similar, more potent drugs, argues Baker. </p>
<p id="Par10">
<bold> Broad search</bold>
</p>
<p id="Par11"> Glycyrrhizin is the molecule responsible for liquorice's peculiar flavour. It hampers the growth of other viruses, including herpes, and helps restore liver function in patients with hepatitis C. It is currently being assessed as a treatment for HIV infection, as it slows the replication of the virus in cultured cells. </p>
<p id="Par12">The liquorice extract is one of many candidate compounds being tested against SARS. As the epidemic intensified, so too did efforts to find effective drugs.</p>
<p id="Par13">We will need some more experimental drugs to try Rolf Hilgenfeld , Lübeck University</p>
<p id="Par14">In the past two months, for example, Baker and other researchers at USAMRIID have tested over 200,000 compounds, sent in from laboratories across the world. "We're using a combination of brute force - screening just about every compound we can get our hands on - and a more rational approach - screening drugs that have already been licensed," says Baker. The team has yet to publish its results.</p>
<p id="Par15">Even if glycyrrhizin or similar drugs are found to work in culture, they will still be a long way off the clinic. Researchers will need to pin down how the compounds operate, and test them in human cells and in animals. "We also need to work out how easily the drug gets into people, how long it stays around and how quickly it's eliminated," says Baker. </p>
<p id="Par16">Even then results can be disappointing when drugs are tested on people. Ribavirin is losing popularity amongst Asian doctors who feel it does not benefit SARS-infected patients.</p>
<p id="Par17">"The research needs intensifying," says Hilgenfeld. "We are likely to see a decline in the disease over the summer before probably coming back in the winter - so we will need some more experimental drugs to try."</p>
</body>
<back>
<fn-group>
<fn>
<p> Lübeck University</p>
</fn>
</fn-group>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cinatl</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus</article-title>
<source>The Lancet</source>
<year>2003</year>
<volume>361,</volume>
<fpage>2045 </fpage>
<lpage> 2046</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(03)13615-X</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000242  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000242  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021